Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|April 3, 2021
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-AnalysisMargarita Majem, Manuel Cobo, Dolores Isla, et al.
European Journal of Cancer Care|October 2, 2019
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancerEva María Ciruelos, María Nieves Díaz, María Dolores Isla, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2023
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual SymposiumNuria Viñolas, Laura Mezquita, Jesús Corral, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of advanced colorectal cancerRocío García-Carbonero, M Auxiliadora Gómez España, Enrique Casado Sáenz, et al.
Cancers|October 17, 2020
From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with ImmunotherapyAndrea Sesma, Julián Pardo, Mara Cruellas, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2026
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studiesMauricio Burotto, Zanete Zvirbule, Renzo Alvarez, et al.
Clinical Lung Cancer|May 29, 2020
Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter StudyTeresa Moran, Alvaro Taus, Edurne Arriola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2016
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish RegionsJavier Salvador, Jorge Aparicio, Francisco Javier Baron, et al.
Clinical Drug Investigation|July 31, 2024
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung CancerEdurne Arriola, Javier de Castro, Rosario García-Campelo, et al.
Clinical Lung Cancer|November 24, 2004
Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancerAngel Artal-Cortés, Jose Gomez-Codina, Jose Luis Gonzalez-Larriba, et al.
Pageof 15